Cleared Traditional

K253096 - Chartis Precision Catheter

K253096 is an FDA 510(k) clearance for Chartis Precision Catheter, manufactured by Pulmonx Corporation. The device is a Class 2 Anesthesiology device with product code CBI cleared through the Traditional 510(k) pathway after a 143-day FDA review.

K253096 · Pulmonx Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2026
Decision
143d
Days
Class 2
Risk

K253096 is an FDA 510(k) clearance for the Chartis Precision Catheter. Classified as Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector) (product code CBI), Class II - Special Controls.

Submitted by Pulmonx Corporation (Redwood City, US). The FDA issued a Cleared decision on February 13, 2026 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5740 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pulmonx Corporation devices

FDA 510(k) Submission Details - K253096

510(k) Number K253096 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2025
Decision Date February 13, 2026
Days to Decision 143 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 140d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CBI Device Classification - Class 2, Special Controls

Product Code CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)

All 19
Devices cleared under the same product code (CBI) and FDA review panel - the closest regulatory comparables to K253096.
Endobronchial Blocker Tube (EBT0109)
K251950 · Hangzhou Tappa Medical Technology Co., Ltd. · Mar 2026
Disposable Double Lumen Endobronchial Tube
K232529 · Shenzhen Insighters Medical Technology Co., Ltd. · May 2024
Disposable Endobronchial Blocker Tube
K232580 · Shenzhen Insighters Medical Technology Co., Ltd. · Dec 2023
Chartis Precision Catheter
K222340 · Pulmonx Corporation · Dec 2022
sOLVe Tube
K201026 · Hytek Medical, Inc. · Aug 2021
Ambu VivaSight 2 DLT, Ambu VivaSight 2 Adapter Cable
K203749 · Ambu A/S · May 2021